P. A.
Peixoto§
,
M.
Cormier
,
J.
Ekosso Epane
,
A.
Jean
,
J.
Maddaluno
and
M.
De Paolis
*
Laboratoire COBRA, CNRS UMR 6014 & FR 3038, Université et INSA de Rouen, 76821-Mont Saint-Aignan, France. E-mail: michael.depaolis@univ-rouen.fr
First published on 16th June 2014
A metal-free procedure is described for the aerobic and complete C–H methylene oxidation of Hajos–Parrish enones to versatile dihydroindenediones. The synthetic utility of these substrates was illustrated by converting them into highly substituted indanes after an intramolecular Friedel–Crafts conjugate addition. Importantly, the aerobic oxidation was compatible with substrates sensitive to radicals.
Metal-free C–H aerobic α-oxidation of electron-withdrawing moieties presents several advantages. In addition to the simplicity of air or oxygen as the oxidant and the absence of metals, the preformation of an alkyl or silyl enol ether is not required as in the typical Rubottom oxidation.7 The added-value of this methodology was demonstrated on ketones, nitriles, imines, esters and enones, leading to the corresponding peroxides, hydroxyls or fragmented products such as ketones depending on the moieties in the vicinity of the peroxide or the presence of reductants.8 Interestingly, when γ-oxidation of enones was performed, the corresponding peroxides or hydroxyls were obtained instead of the ketones.9 For the synthetic study of aplykurodinone-1 (4), we described the γ-aerobic oxidation of the enone 7 in the presence of 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) and a catalytic amount of Cu(OAc)2 to produce the dienedione 8 in 52% yield (Scheme 1C).4b The extension of this protocol to enones containing benzylic appendages such as 1a was investigated and the results are presented herein.
Scheme 2 PTSA: p-toluenesulfonic acid; TMG: N,N,N′,N′-tetramethylguanidine; TBD: 1,5,7-triazabicyclo[4.4.0]dec-5-ene. aAverage yield of two experiments. |
Increasing the amount of DBU (1.4 equiv.) completed the reaction in 36 h and 3a was isolated in 41% yield.10 Increasing further to 1.5 equiv. the amount of DBU led to lower yield and we assumed that 3a, as a Michael acceptor, was to some extent sensitive to nucleophiles such as DBU.11 While less nucleophilic bases than DBU are available, the strength and tolerance to oxygen are key requirements and a screening of bases such as guanidines, trialkylamines, lutidine, alkoxides or inorganic bases led to lower conversion or no oxidation at all (see Scheme 2B). Somewhat counterintuitively, the solvent in which oxygen is more soluble such as DMF or fluorobenzene was less efficient to promote the reaction, indicating that the polarity and oxygen solubility have to be finely tuned.12 To reduce the concentration of DBU and limit therefore the risk of degradation, a sub-stoichiometric amount of DBU was introduced. After screening of conditions, involving different concentrations, amounts of base, induction time and the use of a syringe pump, we found that adding 0.2 equiv. of DBU to 1a followed by heating (12 h) and portionwise addition of DBU (0.2 equiv. every 1.5 h, for a total of 1.4 equiv.) provided the best result. Proceeding in this way, we were able to isolate 3a in 54% yield after 36 h (Scheme 2B). It is noteworthy that the C3 methylene position is oxidised exclusively to the corresponding ketone during the process. Importantly, this procedure has been repeated several times by different experimentalists and provided consistent results.
Once the optimization was completed, we investigated the compatibility of the chemistry with various substituents at the neopentyl position. Hence, mesylates 1b–e containing naphthyl, p-methoxyphenyl, o-bromophenyl and o-nitrophenyl substituents were prepared and tested (see ESI‡ for details). Remarkably, dihydroindenediones 3b–e were obtained with uniform efficiency in yields ranging from 43 to 54% with the exception of the o-nitrophenyl derivative 3e which was isolated in 31% yield (Scheme 3). Applying the optimized protocol to the allyl-substituted 1f led to the oxidised product 3f in 35% yield. Still, substituted with an allyl group, 3f is a promising substrate for synthetic transformations. As expected for alkane substituted substrates, 1g and 1h were converted more efficiently into 3g (46%) and 3h (50%). From a practical point, the crude mixture obtained was very clean in all cases, facilitating the purification of 3a–h.13
Scheme 3 Direct preparation of 3b–h from the corresponding mesylates 1b–h using the optimized protocol. aAverage yield of two experiments. |
Even though no detailed mechanistic study was conducted, some observations can be made from experiments. Hence, the oxidation at C3 appears to be the first step since there is no elimination of the mesylate when the reaction is conducted in the absence of oxygen.
To begin with, the formation of the thermodynamic dienolate 10a (R1 = Ph, R2 = Me) can be reasonably postulated (Scheme 4A). A first mechanism could involve a single electron transfer (SET) to oxygen to produce the radical species 11a and 12a which, after combination with the superoxide radical anion, could form the peroxides 13a and 14a. As a Mislow–Evans rearrangement of allylic sulfoxide, allylic peroxide 14a could undergo [2,3]-sigmatropic rearrangement to produce 13a.
To explain the unusual formation of a ketone at C3, a Kornblum–DeLamare rearrangement of peroxide 13a by intra- or intermolecular deprotonation (with DBU) could be invoked to generate 2a.14 The production of hydroxide would trigger the elimination of mesylate and conclude the process. As postulated by Gersmann, an alternative non-radical mechanism could involve the direct combination of dienolate 10a and oxygen to provide the regioisomeric peroxides 13a and 14a.9b,c With the benzylic substrate 1a and the methyl substrate 1h being oxidised with the same efficiency (54% of 3a and 50% of 3h), it seems unlikely that radical species are involved since 1,5-hydrogen atom abstraction from the benzylic position of 11a/12a or radical 5-exo-trig cyclization (see Scheme 4A) could probably occur. These side reactions would be favored on arenes substituted with electron withdrawing or donating groups stabilizing radical species. In this regard, the smooth oxidation of compounds 1c and 1d containing p-methoxy and o-bromo substituents into 3c (43%) and 3d (54%) uphold the hypothesis that an anionic scenario may predominate. Moreover, the process was unaffected by the exclusion of light. Therefore, it seems plausible that an anionic pathway is active during this process even if we cannot completely rule out a competitive and parallel radical cage mechanism being operative since the oxidation of o-nitrobenzylic and allylic substituted enones 1e and 1f was less efficient, but these two appendages are very sensitive to radicals and bases.
The regioselectivity of the reaction on enones that are not α-substituted such as 1i was next investigated (Scheme 4B). Indeed, the Kornblum–DeLamare rearrangement of peroxide 14i (R2 = R1 = H) could lead to unstable 1,2-diketone under these conditions. To investigate this scenario, 1i was oxidised under the optimized conditions delivering 3i in 33% yield. In comparison, the α-substituted enone 1h was converted into 3h in 50% yield, indicating clearly that α-substituted enones are more efficiently oxidised in the γ-position with this protocol.
To illustrate the utility of these scaffolds, an internal Friedel–Crafts conjugate addition was implemented (Scheme 5). After screening of Brønsted and Lewis acids, the best results were obtained with AlCl3.15 Hence, 3a was efficiently converted into indane 15a (84%) featuring an all-carbon quaternary center embedded into a tetracyclic framework. Similarly, the naphthyl derivative 3b provided regioselectively 15b in 61% yield by reaction at the sp2 carbon with the highest electronic density.
Scheme 5 Reagents and conditions: (a) AlCl3 (5 equiv.), CH2Cl2, rt; (b) Grubbs 2nd generation (2 mol%), ethyl acrylate (6 equiv.), CH2Cl2, rt. |
Interestingly, 3d was converted into versatile 15d (70%), a compound calling for various C–Br modifications toward molecular diversity. Unexpectedly, similar treatment of allylic substrate 3f did not produce the cyclized product but yielded the Markovnikov hydrochloration adduct 16 (60%) with a modest stereoselectivity (dr = 1:1.7). As a further illustration of the potential of 3f, cross-metathesis afforded acrylate 17 (55% yield not optimized) as a promising template for double Michael reactions.
3a: According to the general procedure, the reaction of mesylate 1a (201 mg, 0.60 mmol) and DBU (7 × 18 μL, 0.84 mmol) in toluene (6 mL) provided 3a (83 mg, 55%) as a yellow amorphous solid (cyclohexane–EtOAc/7:3). Rf = 0.5 (cyclohexane–EtOAc, 7:3); IR (film) ν 3027, 2937, 1690, 1668, 1639, 1451, 1181, 820, 738, 701, 469 cm−1; 1H NMR (300 MHz, CDCl3) δ 7.25 (d, J = 6.1 Hz, 1H), 7.07–7.32 (m, 3H), 6.78–6.95 (m, 2H), 6.17 (d, J = 6.1 Hz, 1H), 2.71–3.01 (m, 3H), 2.58 (ddd, J = 19.4, 6.2, 1.5 Hz, 1H), 2.19 (ddd, J = 13.3, 5.8, 1.5 Hz, 1H), 2.10 (s, 3H), 1.86 (ddd ∼ dt, J = 13.3, 6.2 Hz, 1H); 13C NMR (75 MHz, CDCl3) δ 200.0, 196.8, 162.8, 150.4, 135.7, 134.9, 134.3, 130.0 (2C), 128.4 (2C), 127.0, 47.8, 43.0, 33.9, 29.0, 9.8; HRMS (API): calcd for C17H17O2+ [M + H]+: 253.1229, found 253.1227
3b: According to the general procedure, the reaction of mesylate 1b (354 mg, 0.92 mmol) and DBU (7 × 28 μL, 1.29 mmol) in toluene (9.2 mL) provided 3b (136 mg, 49%) as a yellow amorphous solid (cyclohexane–EtOAc/7:3). Rf = 0.45 (cyclohexane–EtOAc, 65:35); IR (film) ν 2965, 1692, 1670, 1258, 1072, 1012, 816, 734, 475 cm−1; 1H NMR (300 MHz, CDCl3) δ 7.65–7.88 (m, 3H), 7.39–7.51 (m, 3H), 7.35 (d, J = 6.1 Hz, 1H), 7.08 (dd, J = 8.4, 1.7 Hz, 1H), 6.23 (d, J = 6.1 Hz, 1H), 3.15 (d, J = 13.4 Hz, 1H), 2.92–3.10 (m, 2H), 2.69 (ddd, J = 19.3, 6.1, 1.2 Hz, 1H), 2.26 (ddd, J = 13.3, 5.9, 1.2 Hz, 1H), 2.21 (s, 3H), 1.93 (ddd ∼ dt, J = 13.3, 6.1 Hz, 1H); 13C NMR (75 MHz, CDCl3) δ 200.1, 196.7, 162.8, 150.5, 134.9, 134.3, 133.2, 133.2, 132.2, 128.7, 128.0, 127.9, 127.6, 127.5, 126.3, 125.9, 47.9, 43.1, 34.0, 28.9, 9.8; HRMS (API): calcd for C21H19O2+ [M + H]+: 303.1385, found 303.1387.
3c: According to the general procedure, the reaction of mesylate 1c (200 mg, 0.55 mmol) and DBU (7 × 17 μL, 0.77 mmol) in toluene (5.5 mL) provided 3c (66 mg, 43%) as a yellow amorphous solid (cyclohexane–EtOAc/7:3). Rf = 0.4 (cyclohexane–EtOAc, 65:35); IR (film) ν 2921, 2854, 1692, 1670, 1613, 1510, 1445, 1305, 1245, 1176, 1030, 816, 516 cm−1; 1H NMR (300 MHz, CDCl3) δ 7.30 (d, J = 6.1 Hz, 1H), 6.87 (d, J = 8.7 Hz, 2H), 6.73–6.82 (m, 2H), 6.23 (d, J = 6.1 Hz, 1H), 3.76 (s, 3H), 2.81–3.01 (m, 3H), 2.63 (ddd, J = 19.3, 6.1, 1.2 Hz, 1H), 2.20 (ddd, J = 13.3, 5.8, 1.2 Hz, 1H), 2.15 (s, 3H), 1.92 (ddd ∼ dt, J = 13.3, 6.1 Hz, 1H); 13C NMR (75 MHz, CDCl3) δ 200.1, 196.8, 162.9, 158.5, 150.5, 134.9, 134.1, 131.0 (2C), 127.6, 113.7 (2C), 55.1, 47.9, 42.1, 33.9, 28.9, 9.8; HRMS (API): calcd for C18H19O3+ [M + H]+: 283.1334, found 283.1351.
3d: According to the general procedure, the reaction of mesylate 1d (200 mg, 0.48 mmol) and DBU (7 × 14 μL, 0.67 mmol) in toluene (4.8 mL) provided 3d (85 mg, 54%) as a yellow amorphous solid (cyclohexane–EtOAc/7:3). Rf = 0.4 (cyclohexane–EtOAc, 65:35); IR (film) ν 2977, 2937, 1669, 1441, 1179, 1126, 1063, 1023, 950, 830, 764, 445 cm−1; 1H NMR (300 MHz, CDCl3) δ 7.49 (d, J = 6.0 Hz, 1H), 7.45 (dd, J = 8.0, 1.4 Hz, 1H), 7.14 (td, J = 7.5, 1.4 Hz, 1H), 7.02 (td, J = 8.0, 1.6 Hz), 6.87 (dd, J = 7.5, 1.6 Hz, 1H), 6.12 (d, J = 6.0 Hz, 1H), 3.38 (d, J = 13.4 Hz, 1H), 3.09 (d, J = 13.4 Hz, 1H), 2.99 (ddd, J = 19.3, 13.5, 5.8 Hz, 1H), 2.67 (ddd, J = 19.3, 6.1, 1.5 Hz, 1H), 2.31 (ddd, J = 13.5, 5.8, 1.5 Hz, 1H), 2.12 (s, 3H), 2.06 (ddd ∼ dt, J = 13.3, 6.1 Hz, 1H); 13C NMR (75 MHz, CDCl3) δ 199.9, 196.4, 161.3, 149.2, 135.1, 135.0, 134.8, 133.1, 132.2, 128.8, 127.1, 125.8, 48.5, 41.1, 33.9, 30.8, 9.8; HRMS (ESI): calcd for C17H16O2Br+ [M + H]+: 331.0334 and 333.0313, found 331.0339 and 333.0320.
3e: According to the general procedure, the reaction of mesylate 1e (569 mg, 1.5 mmol) and DBU (7 × 45 μL, 2.1 mmol) in toluene (15 mL) provided 3e (136 mg, 31%) as a pale yellow amorphous solid (cyclohexane–EtOAc/7:3). Rf = 0.35 (cyclohexane–EtOAc, 6:4); IR (film) ν 2915, 2848, 1691, 1674, 1522, 1462, 1349, 1171, 1080, 841, 827, 784, 747, 710, 472 cm−1; 1H NMR (300 MHz, CDCl3) δ 7.86 (dd, J = 7.8, 1.3 Hz, 1H), 7.44 (td, J = 7.5, 1.5 Hz, 1H), 7.36 (d, J = 6.0 Hz, 1H), 7.36 (td, J = 7.8, 1.5 Hz, 1H), 6.94 (dd, J = 7.5, 1.3 Hz, 1H), 6.06 (d, J = 6.0 Hz, 1H), 3.58 (d, J = 13.3 Hz, 1H), 3.52 (d, J = 13.3 Hz, 1H), 2.94 (ddd, J = 19.4, 13.5, 5.8 Hz, 1H), 2.70 (ddd, J = 19.4, 6.1, 1.4 Hz, 1H), 2.32 (ddd, J = 13.5, 5.8, 1.4 Hz, 1H), 2.12 (s, 3H), 2.11 (ddd ∼ dt, J = 13.5, 6.1 Hz, 1H); 13C NMR (75 MHz, CDCl3) δ 199.5, 196.1, 160.9, 150.0, 148.7, 135.4, 135.1, 133.7, 132.7, 130.7, 128.4, 125.2, 48.6, 38.2, 33.8, 31.2, 9.8; HRMS (API): calcd for C17H16NO4+ [M + H]+: 298.1079, found 298.1079.
3f: According to the general procedure, the reaction of mesylate 1f (150 mg, 0.52 mmol) and DBU (7 × 16 μL, 0.73 mmol) in toluene (10 mL) provided 3f (36 mg, 35%) as a pale yellow amorphous solid (cyclohexane–EtOAc/8:2). Rf = 0.5 (cyclohexane–EtOAc, 6:4); IR (film) ν 2925, 2855, 1694, 1674, 1638, 1451, 1178, 1099, 1072, 1021, 824 cm−1; 1H NMR (300 MHz, CDCl3) δ 7.44 (d, J = 6.1 Hz, 1H), 6.34 (d, J = 6.1 Hz, 1H), 5.50–5.71 (m, 1H), 5.11 (d, J = 10.0 Hz, 1H), 5.03 (dd, J = 16.9, 1.3 Hz, 1H), 2.76 (ddd, J = 19.4, 13.3, 5.7 Hz, 1H), 2.55 (ddd, J = 19.4, 6.2, 1.4 Hz, 1H), 2.46 (dd, J = 13.8, 7.9 Hz, 1H), 2.31 (dd, J = 13.9, 7.1 Hz, 1H), 2.21 (ddd, J = 13.3, 5.7, 1.4 Hz, 1H), 2.12 (s, 3H), 1.91 (ddd ∼ dt, J = 13.3, 6.2 Hz, 1H); 13C NMR (75 MHz, CDCl3) δ 200.2, 197.2, 162.8, 150.2, 135.1, 134.3, 132.3, 119.6, 46.8, 41.1, 33.6, 29.0, 9.8; HRMS (API): calcd for C13H15O2+ [M + H]+: 203.1072, found 203.1072.
3g: According to the general procedure, the reaction of mesylate 1g (357 mg, 1.0 mmol) and DBU (7 × 30 μL, 1.4 mmol) in toluene (10 mL) provided 3g (117 mg, 46%) as a pale yellow amorphous solid (cyclohexane–EtOAc/7:3). Rf = 0.4 (cyclohexane–EtOAc, 8:2); IR (film) ν 2925, 2856, 1694, 1674, 1638, 1456, 1178, 1072, 825 cm−1; 1H NMR (300 MHz, CDCl3) δ 7.43 (d, J = 6.1 Hz, 1H), 6.35 (d, J = 6.1 Hz, 1H), 2.75 (ddd, J = 19.2, 13.2, 5.8 Hz, 1H), 2.54 (ddd, J = 19.2, 6.1, 1.5 Hz, 1H), 2.17 (ddd, J = 13.2, 5.8, 1.5 Hz, 1H), 2.12 (s, 3H), 1.90 (ddd ∼ dt, J = 13.2, 6.1 Hz, 1H), 1.31–1.74 (m, 1H), 1.20 (br s, 10H), 0.95–1.10 (m, 1H), 0.84 (t, J = 6.8 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 200.4, 197.5, 163.4, 150.9, 135.0, 133.6, 46.8, 36.5, 33.7, 31.6, 29.8, 29.7, 28.9, 25.2, 22.4, 13.9, 9.7; HRMS (API): calcd for C17H25O2+ [M + H]+: 261.1855, found 261.1861.
3h: According to the general procedure, the reaction of mesylate 1h (256 mg, 1.0 mmol) and DBU (7 × 30 μL, 1.4 mmol) in toluene (10 mL) provided 3h (88 mg, 50%) as a yellow amorphous solid (cyclohexane–EtOAc/7:3). Rf = 0.45 (cyclohexane–EtOAc, 6:4); IR (film) ν 2921, 2870, 1693, 1664, 1641, 1336, 1217, 1149, 1007, 950, 827, 468 cm−1; 1H NMR (300 MHz, CDCl3) δ 7.48 (d, J = 6.0 Hz, 1H), 6.25 (d, J = 6.0 Hz, 1H), 2.78 (ddd, J = 19.1, 12.9, 6.1 Hz, 1H), 2.57 (ddd, J = 19.1, 5.8, 2.1 Hz, 1H), 2.10 (s, 3H), 2.04 (dd, J = 6.1, 2.1 Hz, 1H), 1.98 (ddd ∼ dt, J = 12.9, 5.8 Hz, 1H), 1.32 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 200.2, 197.4, 165.2, 150.9, 133.6 (2C), 43.5, 33.9, 31.4, 23.8, 9.6; HRMS (ESI): calcd for C11H13O2+ [M + H]+: 177.0916, found 177.0910.
3i: According to the general procedure, the reaction of mesylate 1i (100 mg, 1.0 mmol) and DBU (7 × 18 μL, 1.4 mmol) in toluene (4 mL) provided 3i (22 mg, 33%) as a yellow amorphous solid (cyclohexane–EtOAc/7:3). Rf = 0.45 (cyclohexane–EtOAc, 6:4); IR (film) ν 2928, 1680, 1351, 1173, 1074, 958, 845, 818, 530 cm−1; 1H NMR (300 MHz, CDCl3) δ 7.60 (dd, J = 6.0, 1.0 Hz, 1H), 6.34 (d, J = 6.0 Hz, 1H), 6.27 (br s, 1H), 2.80 (ddd, J = 19.0, 13.3, 5.7 Hz, 1H), 2.56–2.66 (m, 1H), 2.14 (ddd, J = 12.9, 5.6, 2.0 Hz), 2.05 (dd, J = 13.1, 5.5 Hz, 1H), 1.41 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 199.1, 195.7, 166.4, 159.1, 133.2, 121.4, 43.1, 34.7, 32.3, 23.6; HRMS (ESI): calcd for C10H9O2− [M − H]−: 161.0603, found 161.0600.
15a: According to the general procedure, the reaction of 3a (50 mg, 0.2 mmol) and AlCl3 (133 mg, 1.0 mmol) in CH2Cl2 (4 mL) provided 15a (42 mg, 84%) as a yellow oil (cyclohexane–EtOAc/8:2). Rf = 0.60 (cyclohexane–EtOAc, 7:3); IR (film) ν 2915, 1711, 1671, 1619, 1160, 1138, 1058, 813, 782, 760, 470, 425 cm−1; 1H NMR (300 MHz, CDCl3) δ 7.09–7.27 (m, 5H), 3.29 (t, J = 9.7 Hz, 1H), 3.20 (d, J = 16.5 Hz, 1H), 2.93 (t, J = 4.6 Hz, 1H), 2.86 (d, J = 9.7 Hz, 1H), 2.67 (ddd, J = 19.4, 14.2, 5.4 Hz, 1H), 2.48 (ddd, J = 19.4, 4.8, 2.0 Hz, 1H), 2.23 (dd, J = 19.6, 9.0 Hz, 1H), 2.07 (s, 3H), 2.01–2.14 (m, 1H), 1.92 (ddd ∼ dt, J = 14.2, 4.8 Hz, 1H); 13C NMR (75 MHz, CDCl3) δ 208.1, 200.7, 151.2, 145.1, 140.3, 136.2, 127.4, 127.2, 125.4, 124.7, 52.4, 50.8, 45.3, 39.5, 33.8, 33.3, 10.0; HRMS (API): calcd for C17H17O2+ [M + H]+: 253.1229, found 253.1230.
15b: According to the general procedure, the reaction of 3b (20 mg, 0.07 mmol) and AlCl3 (47 mg, 0.35 mmol) in CH2Cl2 (5 mL) provided indane 15b (17 mg, 80%) as a yellow oil (cyclohexane–EtOAc/8:2). Rf = 0.60 (cyclohexane–EtOAc, 65:35); IR (film) ν 3055, 2921, 2848, 1712, 1672, 1618, 1378, 1186, 1159, 1137, 1058, 811, 782, 730, 467 cm−1; 1H NMR (300 MHz, CDCl3) δ 7.86–7.94 (m, 1H), 7.76 (t, J = 7.6 Hz, 2H), 7.45–7.58 (m, 2H), 7.38 (d, J = 8.4 Hz, 1H), 3.86 (t, J = 9.3 Hz, 1H), 3.47 (d, J = 16.6 Hz, 1H), 3.12–3.27 (m, 2H), 2.83 (ddd, J = 18.3, 14.1, 5.4 Hz, 1H), 2.60 (ddd, J = 18.3, 4.9, 2.1 Hz, 1H), 2.37 (dd, J = 19.7, 8.7 Hz, 1H), 2.24 (ddd, J = 14.1, 5.4, 2.1 Hz, 1H), 2.20 (s, 3H), 2.16 (ddd ∼ dt, J = 14.1, 4.9 Hz, 1H); 13C NMR (75 MHz, CDCl3) δ 208.3, 200.8, 151.2, 140.9, 137.3, 136.2, 133.1, 130.1, 128.7, 128.2, 126.6, 125.4, 123.7, 123.5, 52.4, 49.3, 44.8, 40.8, 34.1, 33.9, 10.1; HRMS (API): calcd for C21H19O2+ [M + H]+: 303.1385, found 303.1385.
15d: According to the general procedure, the reaction of 3d (10 mg, 0.03 mmol) and AlCl3 (28 mg, 0.21 mmol) in CH2Cl2 (5 mL) provided 15d (7 mg, 70%) as a yellow powder (cyclohexane–EtOAc/8:2). Rf = 0.50 (cyclohexane–EtOAc, 7:3); IR (film) ν 2919, 2854, 1713, 1673, 1449, 1180, 1129, 1062, 959, 780 cm−1; 1H NMR (300 MHz, CDCl3) δ 7.39 (d, J = 7.9 Hz, 1H), 7.21 (d, J = 7.4 Hz, 1H), 7.06–7.14 (m, 1H), 3.48 (t, J = 9.4 Hz, 1H), 3.38 (d, J = 17.1 Hz, 1H), 2.90–3.05 (m, 2H), 2.74 (ddd, J = 19.6, 14.1, 5.3 Hz, 1H), 2.59 (ddd, J = 18.3, 4.8, 1.9 Hz, 1H), 2.32 (dd, J = 19.6, 8.8 Hz, 1H), 2.21 (ddd, J = 13.1, 5.3, 1.9 Hz, 1H), 2.16 (s, 3H), 2.09 (ddd ∼ dt, J = 14.1, 4.8 Hz, 1H); 13C NMR (75 MHz, CDCl3) δ 208.3, 200.8, 151.2, 140.9, 137.3, 136.2, 133.1, 130.1, 128.7, 128.2, 126.6, 125.4, 123.7, 123.5, 52.4, 49.3, 44.8, 40.8, 34.1, 33.9, 10.1; HRMS (API): calcd for C17H16O2Br+ [M + H]+: 331.0334 and 333.0313, found 331.0331 and 333.0307.
16: According to the general procedure, the reaction of dihydroindenedione 3f (24 mg, 0.12 mmol) and AlCl3 (80 mg, 0.6 mmol) in CH2Cl2 (5 mL) provided a stereoisomeric mixture of diastereoisomer 16 (6 mg, 21%) and 16′ (11 mg, 39%) as a colorless oil (cyclohexane–EtOAc/8:2 to 7:3). 16: Rf = 0.5 (cyclohexane–EtOAc, 6:4); IR (film) ν 3072, 2927, 2848, 1695, 1665, 1445, 1316, 1184, 1020, 844, 828, 710, 615, 506, 404 cm−1; 1H NMR (300 MHz, CDCl3) δ 7.63 (d, J = 6.1 Hz, 1H), 6.42 (d, J = 6.1 Hz, 1H), 3.84 (m, 1H), 2.83 (ddd, J = 19.5, 13.2, 5.6 Hz, 1H), 2.60 (ddd, J = 19.5, 6.2, 1.2 Hz, 1H), 2.46 (ddd, J = 13.2, 5.6, 1.2 Hz, 1H), 2.32 (dd, J = 15.2, 8.5 Hz, 1H), 2.15 (s, 3H), 1.97 (dd, J = 15.2, 3.8 Hz, 1H), 1.88 (ddd ∼ dt, J = 13.2, 6.2 Hz, 1H), 1.44 (d, J = 6.6 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 200.1, 196.9, 162.6, 149.9, 135.8, 134.8, 54.3, 46.8, 46.4, 33.9, 30.4, 27.1, 10.0; HRMS (API): calcd for C13H16O2Cl [M + H+]: 239.0839, found 239.0834. 16′: Rf = 0.35 (cyclohexane–EtOAc, 6:4); IR (film) ν 2926, 1674, 1186, 825, 617 cm−1; 1H NMR (300 MHz, CDCl3) δ 7.58 (d, J = 6.1 Hz, 1H), 6.41 (d, J = 6.1 Hz, 1H), 3.78–4.05 (m, 1H), 2.69 (ddd, J = 19.3, 13.2, 5.3 Hz, 1H), 2.57 (ddd, J = 19.3, 6.6, 1.8 Hz, 1H), 2.21 (ddd, J = 13.2, 5.3, 1.8 Hz, 1H), 2.14 (s, J = 3.6 Hz, 3H), 2.08–2.17 (m, 2H), 1.95 (ddd ∼ dt, J = 13.2, 6.6 Hz, 1H), 1.50 (d, J = 6.6 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 199.8, 196.7, 161.5, 150.5, 135.6, 133.8, 53.9, 46.7, 46.3, 33.7, 31.0, 26.5, 9.9; HRMS (API): calcd for C13H16O2Cl [M + H]+: 239.0839, found 239.0845.
17: To a stirred solution of 3f (24 mg, 0.060 mmol) and ethyl acrylate (40 μL, 0.360 mmol) in CH2Cl2 (5 mL) at rt was added Grubbs II catalyst (10 mg, 0.0012 mmol). The resulting mixture was stirred for 12 h before being concentrated in vacuo. Flash column chromatography (cyclohexane–EtOAc, 70:30) of the crude afforded acrylate 17 (18 mg, 55%) as a yellow oil. Rf = 0.55 (cyclohexane–EtOAc, 60:40); IR (film) ν 3029, 2927, 1653, 1352, 1331, 1173, 1017, 940, 843, 743, 702 cm−1; 1H NMR (300 MHz, CDCl3) δ 7.49 (d, J = 6.1 Hz, 1H), 6.76 (m, 1H), 6.39 (d, J = 6.1 Hz, 1H), 5.83 (d, J = 15.5 Hz, 1H), 4.17 (q, J = 7.1 Hz, 2H), 2.53–2.81 (m, 3H), 2.38 (dd, J = 14.0, 7.4 Hz, 1H), 2.23 (dd, J = 13.2, 4.3 Hz, 1H), 2.14 (s, 3H), 1.94 (ddd ∼ dt, J = 13.2, 6.4 Hz, 1H), 1.27 (t, J = 7.1 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 199.7, 196.5, 165.5, 161.9, 149.4, 141.8, 135.6, 135.0, 125.6, 60.6, 46.7, 39.5, 33.5, 28.9, 14.2, 9.9; HRMS (API): calcd for C16H19O4+ [M + H]+: 275.1283, found 275.1276.
Footnotes |
† Dedicated to Professor Max Malacria. |
‡ Electronic supplementary information (ESI) available: Procedures for the preparations of 1a–i and spectra of all compounds. See DOI: 10.1039/c4qo00125g |
§ Current address: Institut Européen de Chimie et Biologie, 2 rue Robert Escarpit, 33607 Pessac Cedex, France. |
This journal is © the Partner Organisations 2014 |